Key result
Pulmonary hypertension and right ventricular dysfunction in patients with COVID-19 serve as predictors of a more severe disease course and poor prognosis.
Why the study?
Severe COVID-19 involves extensive cardiopulmonary damage, making the early detection of markers of severity and the evaluation of pulmonary hypertension and right ventricular dysfunction important for assessing prognosis.
Do pulmonary hypertension and right ventricular dysfunction predict severe disease and poor prognosis in patients with COVID-19?
Do pulmonary hypertension and right ventricular dysfunction predict severe disease and poor prognosis in patients with COVID-19?
Answers are grounded in this paper and cite their sources.
Pulmonary hypertension and right ventricular dysfunction are important prognostic markers for severe disease and mortality in patients with COVID-19.
Coronavirus disease 2019 (COVID-19) is a disease characterized by diverse clinical manifestations, the severity of which can vary from asymptomatic to extremely severe. At this stage, the urgent task is the early detection of reliable markers of its severity in the acute period of infection and possible changes that cause symptoms in the post-COVID period. The severe COVID-19 is associated with extensive damage to the lungs, pulmonary vessels, and cardiovascular system. In this regard, it seems natural to study the problem of pulmonary hypertension (PH) and right ventricular dysfunction (RVD) in patients with COVID-19, and their significance for assessing the severity of the condition and prognosis. Also important is the availability of reliable non-invasive diagnostics. This review presents data on the incidence of PH and RVD and their potential significance in patients with COVID-19. We have analyzed literature sources in the eLIBRARY, PubMed/MEDLINE, ScienceDirect and ProQuest databases.
No takes yet. Share an insight, caveat, or question.
Подзолков et al. (2023) conducted a review in COVID-19. Pulmonary hypertension and right ventricular dysfunction vs. Absence of pulmonary hypertension and right ventricular dysfunction was evaluated on Severity of COVID-19 and mortality. Pulmonary hypertension and right ventricular dysfunction in patients with COVID-19 serve as predictors of a more severe disease course and poor prognosis.
Synapse has enriched 10 related papers. Consider them for comparative context: